Trial Profile
A study of Luseogliflozin : the components of weight loss in the Japanese patients with type 2 diabetes mellitus
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Jan 2017
Price :
$35
*
At a glance
- Drugs Luseogliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Acronyms LIGHT
- 06 Jan 2017 Status changed from recruiting to completed.
- 12 Sep 2014 New trial record